Valuation Myriad Genetics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-06-22 EDT			5-day change	1st Jan Change
4.500 ^USD	-0.88%		+4.17%	-26.83%

06-02	Myriad Genetics, Inc. Announces Appointment of Raj Jampa to Chief Technology Officer, Effective June 1, 2026	CI
05-27	Myriad Genetics Highlights Data Demonstrating Broad Clinical Utility of Precise Mrd Assay At 2026 Asco Annual Meeting	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,204	1,176	1,697	1,248	573.3	425	-	-
Change	-	-46.65%	44.34%	-26.46%	-54.07%	-25.86%	-	-
Enterprise Value (EV)	1,864	1,061	1,595	1,185	543.6	425	425	425
Change	-	-43.09%	50.32%	-25.67%	-54.14%	-21.81%	0%	0%
P/E	-78.9x	-10.4x	-6.02x	-9.72x	-1.56x	-5.92x	-8.49x	-9.28x
PBR	2.28x	1.33x	2.2x	1.79x	1.56x	-	-	-
PEG	-	-0x	-0x	0.2x	-0x	0.1x	0.3x	1.09x
Capitalization / Revenue	3.19x	1.73x	2.25x	1.49x	0.7x	0.49x	0.46x	0.44x
EV / Revenue	0x	0x	0x	0x	0x	0.49x	0.46x	0.44x
EV / EBITDA	0x	-0x	-0x	0x	0x	11.6x	8.75x	-
EV / EBIT	0x	-0x	-0x	0x	0x	37x	15x	8.03x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.35	-1.39	-3.18	-1.41	-3.95	-0.76	-0.53	-0.485
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	690.6	678.4	753.2	837.6	824.5	863.6	915.8	970.1
EBITDA ¹	71.9	-21	-6.3	40.4	38.9	36.67	48.57	-
EBIT ¹	9.1	-32.8	-25.5	21.8	15.1	11.48	28.31	52.9
Net income ¹	-27.2	-112	-263.3	-127.3	-365.9	-71.48	-50.98	-47.29
Net Debt	-339.8	-114.9	-102.4	-62.8	-29.7	-	-	-
Reference price ²	27.600	14.510	19.140	13.710	6.150	4.500	4.500	4.500
Nbr of stocks (in thousands)	79,855	81,034	88,669	91,035	93,214	94,448	-	-
Announcement Date	2/24/22	2/28/23	2/27/24	2/24/25	2/23/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MYRIAD GENETICS, INC.	-5.97x	-	-	-.--%	429M
GUARDANT HEALTH, INC.	-45.43x	13.69x	-100.63x	-.--%	17.47B
BIOMÉRIEUX	16.34x	1.87x	7.6x	1.6%	9.33B
LANTHEUS HOLDINGS, INC.	25.97x	4.44x	12.5x	-	6.76B
CARIS LIFE SCIENCES, INC.	182.38x	4.77x	30.65x	-.--%	5.22B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	17.96x	6.16x	13.93x	3.22%	4.88B
10X GENOMICS, INC.	-42.71x	6.4x	-53.76x	-.--%	4.41B
DIASORIN S.P.A.	19.19x	3.36x	10.45x	2.03%	3.95B
AUTOBIO DIAGNOSTICS CO., LTD.	15.3x	-	-	4.19%	2.57B
Average	20.34x	5.81x	-11.32x	1.38%	6.12B
Weighted average by Cap.	9.06x	7.36x	-30.19x	1.02%